Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
EMV
vs
S
S&P/ASX 300
EMV
Over the past 12 months, EMV has underperformed S&P/ASX 300, delivering a return of -12% compared to S&P/ASX 300's 3% drop.
Stocks Performance
EMV vs S&P/ASX 300
Performance Gap
EMV vs S&P/ASX 300
Performance By Year
EMV vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices is an Australian medical technology company developing a portable brain-imaging device that can help doctors assess stroke and other brain conditions at the point of care. Its core product is designed to scan the brain with electromagnetic technology rather than traditional large hospital scanners, making it easier to use in emergency settings, ambulances, and smaller clinics where speed matters. The company’s main customers are expected to be hospitals, emergency departments, stroke teams, ambulance services, and other healthcare providers that need fast brain assessment tools. EMvision would make money by selling or licensing its devices and related software and support services to healthcare buyers, rather than by treating patients itself. In practice, it sits in the medical equipment part of the healthcare industry, aiming to give clinicians a faster first look before patients are sent for more detailed imaging. What makes the business different is its focus on bringing brain scanning closer to the patient instead of requiring a full hospital imaging suite. That gives it a role as a front-line triage tool: helping medical staff decide who needs urgent treatment or transfer. If widely adopted, its value would come from fitting into existing stroke and emergency workflows rather than replacing standard scanners.
